Mechanisms of body weight reduction and metabolic syndrome alleviation by tea.

PubWeight™: 0.88‹?›

🔗 View Article (PMID 26577614)

Published in Mol Nutr Food Res on December 09, 2015

Authors

Chung S Yang1,2, Jinsong Zhang2,3, Le Zhang1,2, Jinbao Huang2,3, Yijun Wang2,3

Author Affiliations

1: Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ, USA.
2: International Joint Research Laboratory of Tea Chemistry and Health Effects, Anhui Agricultural University, Hefei, Anhui, P. R. China.
3: State Key Laboratory of Tea Plant Biology and Utilization, Anhui Agricultural University, Hefei, Anhui, P. R. China.

Articles cited by this

(truncated to the top 100)

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev (2001) 36.00

AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol (2012) 10.42

Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia (2007) 5.61

Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care (2005) 5.39

The relationship between green tea and total caffeine intake and risk for self-reported type 2 diabetes among Japanese adults. Ann Intern Med (2006) 4.67

Structure of mammalian AMPK and its regulation by ADP. Nature (2011) 4.27

Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study. JAMA (2006) 4.08

Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat Rev Cancer (2009) 3.90

AMP-activated protein kinase signaling in metabolic regulation. J Clin Invest (2006) 3.39

Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans. Am J Clin Nutr (1999) 3.29

Coffee, decaffeinated coffee, and tea consumption in relation to incident type 2 diabetes mellitus: a systematic review with meta-analysis. Arch Intern Med (2009) 2.79

The chemistry of tea flavonoids. Crit Rev Food Sci Nutr (1997) 2.51

Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice. Diabetes (2011) 2.46

A receptor for green tea polyphenol EGCG. Nat Struct Mol Biol (2004) 2.46

The impact of green tea and coffee consumption on the reduced risk of stroke incidence in Japanese population: the Japan public health center-based study cohort. Stroke (2013) 2.27

Long-term green tea extract supplementation does not affect fat absorption, resting energy expenditure, and body composition in adults. J Nutr (2015) 2.01

Metformin activates a duodenal Ampk-dependent pathway to lower hepatic glucose production in rats. Nat Med (2015) 1.91

The major green tea polyphenol, (-)-epigallocatechin-3-gallate, inhibits obesity, metabolic syndrome, and fatty liver disease in high-fat-fed mice. J Nutr (2008) 1.82

Flavonoid intake and the risk of cardiovascular disease in women. Am J Clin Nutr (2003) 1.79

Modulation of endocrine systems and food intake by green tea epigallocatechin gallate. Endocrinology (2000) 1.72

AMPK: positive and negative regulation, and its role in whole-body energy homeostasis. Curr Opin Cell Biol (2014) 1.69

Effects of dietary supplementation with epigallocatechin-3-gallate on weight loss, energy homeostasis, cardiometabolic risk factors and liver function in obese women: randomised, double-blind, placebo-controlled clinical trial. Br J Nutr (2013) 1.69

Mechanism of action of (-)-epigallocatechin-3-gallate: auto-oxidation-dependent inactivation of epidermal growth factor receptor and direct effects on growth inhibition in human esophageal cancer KYSE 150 cells. Cancer Res (2005) 1.60

A constituent of green tea, epigallocatechin-3-gallate, activates endothelial nitric oxide synthase by a phosphatidylinositol-3-OH-kinase-, cAMP-dependent protein kinase-, and Akt-dependent pathway and leads to endothelial-dependent vasorelaxation. J Biol Chem (2003) 1.59

Bioavailability issues in studying the health effects of plant polyphenolic compounds. Mol Nutr Food Res (2008) 1.59

Novel insights of dietary polyphenols and obesity. J Nutr Biochem (2014) 1.58

Associations of dietary flavonoids with risk of type 2 diabetes, and markers of insulin resistance and systemic inflammation in women: a prospective study and cross-sectional analysis. J Am Coll Nutr (2005) 1.57

AMPKalpha1 regulates the antioxidant status of vascular endothelial cells. Biochem J (2009) 1.55

New insights into the mechanisms of polyphenols beyond antioxidant properties; lessons from the green tea polyphenol, epigallocatechin 3-gallate. Redox Biol (2014) 1.53

Structural biology. Division of labor in transhydrogenase by alternating proton translocation and hydride transfer. Science (2015) 1.47

Green and black tea consumption and risk of stroke: a meta-analysis. Stroke (2009) 1.46

Epigallocatechin-3-gallate (EGCG), a green tea polyphenol, suppresses hepatic gluconeogenesis through 5'-AMP-activated protein kinase. J Biol Chem (2007) 1.43

The effects of green tea on weight loss and weight maintenance: a meta-analysis. Int J Obes (Lond) (2009) 1.36

Green tea as inhibitor of the intestinal absorption of lipids: potential mechanism for its lipid-lowering effect. J Nutr Biochem (2007) 1.35

Tea, obesity, and diabetes. Mol Nutr Food Res (2006) 1.30

Antiobesity effects of green tea catechins: a mechanistic review. J Nutr Biochem (2010) 1.29

Structural identification of two metabolites of catechins and their kinetics in human urine and blood after tea ingestion. Chem Res Toxicol (2000) 1.28

Effects of dietary supplementation with the green tea polyphenol epigallocatechin-3-gallate on insulin resistance and associated metabolic risk factors: randomized controlled trial. Br J Nutr (2008) 1.28

Comparison of (-)-epigallocatechin-3-gallate elicited liver and small intestine gene expression profiles between C57BL/6J mice and C57BL/6J/Nrf2 (-/-) mice. Pharm Res (2005) 1.27

Pro-oxidative activities and dose-response relationship of (-)-epigallocatechin-3-gallate in the inhibition of lung cancer cell growth: a comparative study in vivo and in vitro. Carcinogenesis (2010) 1.24

Green tea extract reduces blood pressure, inflammatory biomarkers, and oxidative stress and improves parameters associated with insulin resistance in obese, hypertensive patients. Nutr Res (2012) 1.23

The chemistry and biotransformation of tea constituents. Pharmacol Res (2011) 1.22

Coffee, green tea, black tea and oolong tea consumption and risk of mortality from cardiovascular disease in Japanese men and women. J Epidemiol Community Health (2009) 1.22

Green tea powder and Lactobacillus plantarum affect gut microbiota, lipid metabolism and inflammation in high-fat fed C57BL/6J mice. Nutr Metab (Lond) (2012) 1.20

Effect of green tea catechins with or without caffeine on anthropometric measures: a systematic review and meta-analysis. Am J Clin Nutr (2009) 1.16

Weight control and prevention of metabolic syndrome by green tea. Pharmacol Res (2010) 1.15

Green tea (-)-epigallocatechin-3-gallate reduces body weight with regulation of multiple genes expression in adipose tissue of diet-induced obese mice. Ann Nutr Metab (2009) 1.13

Plasma and tissue levels of tea catechins in rats and mice during chronic consumption of green tea polyphenols. Nutr Cancer (2000) 1.12

Tea and coffee consumption and cardiovascular morbidity and mortality. Arterioscler Thromb Vasc Biol (2010) 1.11

Effects of catechin enriched green tea on body composition. Obesity (Silver Spring) (2009) 1.10

Effects of green tea polyphenol (-)-epigallocatechin-3-gallate on newly developed high-fat/Western-style diet-induced obesity and metabolic syndrome in mice. J Agric Food Chem (2011) 1.08

Black and green tea consumption and the risk of coronary artery disease: a meta-analysis. Am J Clin Nutr (2011) 1.08

Saccharomyces boulardii administration changes gut microbiota and reduces hepatic steatosis, low-grade inflammation, and fat mass in obese and type 2 diabetic db/db mice. MBio (2014) 1.07

Randomized controlled trial for an effect of green tea-extract powder supplementation on glucose abnormalities. Eur J Clin Nutr (2007) 1.05

Acute effects of epigallocatechin gallate from green tea on oxidation and tissue incorporation of dietary lipids in mice fed a high-fat diet. Int J Obes (Lond) (2011) 1.05

Inhibition of human liver catechol-O-methyltransferase by tea catechins and their metabolites: structure-activity relationship and molecular-modeling studies. Biochem Pharmacol (2005) 1.04

Effects of green tea supplementation on elements, total antioxidants, lipids, and glucose values in the serum of obese patients. Biol Trace Elem Res (2012) 1.03

Tea and cardiovascular disease. Pharmacol Res (2011) 1.03

The effects of catechin rich teas and caffeine on energy expenditure and fat oxidation: a meta-analysis. Obes Rev (2011) 1.02

Inverse correlation between coffee consumption and prevalence of metabolic syndrome: baseline survey of the Japan Multi-Institutional Collaborative Cohort (J-MICC) Study in Tokushima, Japan. J Epidemiol (2012) 1.02

Effect of 2-month controlled green tea intervention on lipoprotein cholesterol, glucose, and hormone levels in healthy postmenopausal women. Cancer Prev Res (Phila) (2012) 1.02

(-)-Epigallocatechin-3-gallate inhibits pancreatic lipase and reduces body weight gain in high fat-fed obese mice. Obesity (Silver Spring) (2011) 1.01

Does supplementation with green tea extract improve insulin resistance in obese type 2 diabetics? A randomized, double-blind, and placebo-controlled clinical trial. Altern Med Rev (2011) 1.01

Green tea extract supplementation induces the lipolytic pathway, attenuates obesity, and reduces low-grade inflammation in mice fed a high-fat diet. Mediators Inflamm (2013) 1.00

Epigallocatechin-gallate suppresses tumorigenesis by directly targeting Pin1. Cancer Prev Res (Phila) (2011) 1.00

Green tea polyphenol extract regulates the expression of genes involved in glucose uptake and insulin signaling in rats fed a high fructose diet. J Agric Food Chem (2007) 0.98

Analysis of theaflavins in biological fluids using liquid chromatography-electrospray mass spectrometry. J Chromatogr B Biomed Sci Appl (2001) 0.97

Catechin-induced activation of the LKB1/AMP-activated protein kinase pathway. Biochem Pharmacol (2009) 0.97

Green tea supplementation increases glutathione and plasma antioxidant capacity in adults with the metabolic syndrome. Nutr Res (2013) 0.97

Green and black tea for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev (2013) 0.96

Green tea polyphenols reduced fat deposits in high fat-fed rats via erk1/2-PPARγ-adiponectin pathway. PLoS One (2013) 0.95

Does green tea affect postprandial glucose, insulin and satiety in healthy subjects: a randomized controlled trial. Nutr J (2010) 0.94

Coffee and green tea consumption is associated with insulin resistance in Japanese adults. Metabolism (2013) 0.94

Dietary green tea extract lowers plasma and hepatic triglycerides and decreases the expression of sterol regulatory element-binding protein-1c mRNA and its responsive genes in fructose-fed, ovariectomized rats. J Nutr (2009) 0.94

Effects of green tea on insulin sensitivity, lipid profile and expression of PPARalpha and PPARgamma and their target genes in obese dogs. Br J Nutr (2007) 0.94

Epigallocatechin-3-gallate (EGCG), a green tea polyphenol, stimulates hepatic autophagy and lipid clearance. PLoS One (2014) 0.94

Diet supplementation with green tea extract epigallocatechin gallate prevents progression to glucose intolerance in db/db mice. Nutr Metab (Lond) (2012) 0.93

Black-tea polyphenols decrease micellar solubility of cholesterol in vitro and intestinal absorption of cholesterol in rats. J Agric Food Chem (2010) 0.93

Smoking, habitual tea drinking and metabolic syndrome in elderly men living in rural community: the Tianliao old people (TOP) study 02. PLoS One (2012) 0.93

Pharmacokinetic and chemoprevention studies on tea in humans. Pharmacol Res (2011) 0.93

Tea consumption is inversely associated with weight status and other markers for metabolic syndrome in US adults. Eur J Nutr (2012) 0.93

Ambivalent role of gallated catechins in glucose tolerance in humans: a novel insight into non-absorbable gallated catechin-derived inhibitors of glucose absorption. J Physiol Pharmacol (2009) 0.93

Green tea polyphenol (-)-epigallocatechin-3-gallate triggered hepatotoxicity in mice: responses of major antioxidant enzymes and the Nrf2 rescue pathway. Toxicol Appl Pharmacol (2015) 0.92

Prevention of chronic diseases by tea: possible mechanisms and human relevance. Annu Rev Nutr (2013) 0.91

Tea consumption and ischemic stroke risk: a case-control study in southern China. Stroke (2009) 0.91

Epigallocatechin gallate induces expression of heme oxygenase-1 in endothelial cells via p38 MAPK and Nrf-2 that suppresses proinflammatory actions of TNF-α. J Nutr Biochem (2011) 0.90

Green tea polyphenols improve cardiac muscle mRNA and protein levels of signal pathways related to insulin and lipid metabolism and inflammation in insulin-resistant rats. Mol Nutr Food Res (2010) 0.89

The efficacy of black tea in ameliorating endothelial function is equivalent to that of green tea. Br J Nutr (2007) 0.89

Caffeine activates preferentially α1-isoform of 5'AMP-activated protein kinase in rat skeletal muscle. Acta Physiol (Oxf) (2011) 0.89

Consumption of cocoa, tea and coffee and risk of cardiovascular disease. Eur J Intern Med (2011) 0.88

Metabolic response to green tea extract during rest and moderate-intensity exercise. J Nutr Biochem (2012) 0.87

Dietary supplementation with high dose of epigallocatechin-3-gallate promotes inflammatory response in mice. J Nutr Biochem (2011) 0.87

Endothelium/nitric oxide mechanism mediates vasorelaxation and counteracts vasoconstriction induced by low concentration of flavanols. Eur J Nutr (2012) 0.86

Mechanisms for food polyphenols to ameliorate insulin resistance and endothelial dysfunction: therapeutic implications for diabetes and its cardiovascular complications. Am J Physiol Endocrinol Metab (2013) 0.86

Negative modulation of mitochondrial oxidative phosphorylation by epigallocatechin-3 gallate leads to growth arrest and apoptosis in human malignant pleural mesothelioma cells. Biochim Biophys Acta (2013) 0.85

The role of the mitochondrial oxidative stress in the cytotoxic effects of the green tea catechin, (-)-epigallocatechin-3-gallate, in oral cells. Mol Nutr Food Res (2013) 0.84

Effects of green tea consumption on human fecal microbiota with special reference to Bifidobacterium species. Microbiol Immunol (2012) 0.84

Quercetin, luteolin and epigallocatechin gallate alleviate TXNIP and NLRP3-mediated inflammation and apoptosis with regulation of AMPK in endothelial cells. Eur J Pharmacol (2014) 0.84

Inhibition of starch digestion by the green tea polyphenol, (-)-epigallocatechin-3-gallate. Mol Nutr Food Res (2012) 0.84

Impact of caffeine and coffee on our health. Trends Endocrinol Metab (2014) 0.82